Yan Leyfman, Medical Oncologist, Co-Founder and Executive Director of MedNews Week, shared a post by Jeremy Bellaiche, Founder of Shuf, on LinkedIn, adding:
“New Episode – The Translational Edge
CAR T-cell therapy transformed blood cancers.
But solid tumors? Still one of oncology’s greatest unsolved challenges. So what’s been holding us back-and what’s finally changing?
In this episode, we break down:
- Why CAR T cells fail in solid tumors
- The tumor microenvironment problem
- New breakthroughs: armored CARs, multi-targeting, and in vivo engineering
- What this means for the future of cancer therapy
This is where science meets impact.
Quoting Jeremy Bellaiche on LinkedIn:
“Excited to share episode 4 of The Translational Edge season 2 with Yan Leyfman, exclusively on Shuf!
The program? Teaching Cancer-Fighting Cells to Recharge!”
Other articles featuring Yan Leyfman and Jeremy Bellaiche on OncoDaily.